ROBERT E ABERNATHY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT E ABERNATHY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT E ABERNATHY. ROBERT E ABERNATHY is a Director in LUBRIZOL Corp ($LZ) and a Director in HAEMONETICS CORP ($HAE) and a Director in POLYONE CORP ($POL) and a Chairman and CEO in Halyard Health, Inc. ($HYH) and a President and CEO in Halyard Health, Inc. ($HYH) and a See Remarks in Halyard Health, Inc. ($HYH).
Companies in which ROBERT E ABERNATHY is an Insider
Avanos Medical, Inc.
Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
Position of ROBERT E ABERNATHY: President and CEO, Chairman and CEO, See Remarks
Holdings: 61,677 shares
Current Value: $2,453,511
Latest Transaction: May 05 2017
$HYH Market Capitalization: $1.86B
$HYH Previous Close: $39.78
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AVIENT CORP
Industry: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
Position of ROBERT E ABERNATHY: Director
Holdings: 22,428 shares
Current Value: $752,235
Latest Transaction: Apr 01 2021
$POL Market Capitalization: $2.79B
$POL Previous Close: $33.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HAEMONETICS CORP
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ROBERT E ABERNATHY: Director
Holdings: 12,048 shares
Current Value: $447,583
Latest Transaction: Aug 12 2020
$HAE Market Capitalization: $1.91B
$HAE Previous Close: $37.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LUBRIZOL Corp
Industry: INDUSTRIAL ORGANIC CHEMICALS [2860]
Position of ROBERT E ABERNATHY: Director
Holdings: 3,615 shares
Latest Transaction: Apr 26 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ROBERT E ABERNATHY
Sentiment: All, HYH, POL, HAE, LZ
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | POL | AVIENT CORP | ABERNATHY ROBERT E | Director | Grant | A | 0.00 | 682 | 0 | 22,428 | 21.7 K to 22.4 K (+3.14 %) |
| Jan 04 2021 | POL | AVIENT CORP | ABERNATHY ROBERT E | Director | Grant | A | 0.00 | 804 | 0 | 21,746 | 20.9 K to 21.7 K (+3.84 %) |
| Aug 12 2020 | HAE | HAEMONETICS CORP | ABERNATHY ROBERT E | Director | Buy | P | 80.93 | 4,000 | 323,720 | 12,048 | 8 K to 12 K (+49.70 %) |
| Jul 22 2020 | HAE | HAEMONETICS CORP | ABERNATHY ROBERT E | Director | Grant | A | 0.00 | 1,983 | 0 | 8,048 | 6.1 K to 8 K (+32.70 %) |
| Jul 01 2020 | POL | AVIENT CORP | ABERNATHY ROBERT E | Director | Grant | A | 0.00 | 1,250 | 0 | 19,740 | 18.5 K to 19.7 K (+6.76 %) |
| Apr 01 2020 | POL | POLYONE CORP | ABERNATHY ROBERT E | Director | Grant | A | 0.00 | 1,705 | 0 | 18,490 | 16.8 K to 18.5 K (+10.16 %) |
| Jan 03 2020 | POL | POLYONE CORP | ABERNATHY ROBERT E | Director | Grant | A | 0.00 | 879 | 0 | 16,785 | 15.9 K to 16.8 K (+5.53 %) |